Clinical Trial Update: PACAP38´s (Pituitary Adenylate Cyclase-Activating Polypeptide) Headache Inducing Characteristics and Effects on the Cerebral Blood Flow [NA]

View source ↗

Summary

This clinical trial update describes how PACAP38 can induce headaches and its effects on cerebral blood flow in migraine without aura.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Without Aura

Drugs mentioned

• PACAP38 (pituitary adenylate cyclase-activating polypeptide-38)

Snippet

Sponsor: Danish Headache Center | Conditions: Migraine Without Aura | NA | Status: COMPLETED